Maastricht University | Netherlands
Author Profile
Scopus
Orcid
Early Academic Pursuits đź“š
Dr. Fang Wang's academic journey began with a Bachelor’s degree in Pharmacology from Nanchang University, where she developed an oxidative stress model in LO2 cells to test stress amelioration compounds. She continued her studies with a Master's degree in Cell Biology at the same university, focusing on the role of progesterone adiponectin receptor 7 in reproduction and differences in protein post-translational modifications. Currently, she is pursuing a PhD in Cell Biology at Maastricht University, investigating substrate metabolism in diabetic cardiomyopathy and novel treatments using bioactive components from Traditional Chinese Medicine.
Professional Endeavors 🔬
With over seven years of experience, Dr. Wang has built a strong foundation in preclinical research, drug development, scientific communication, and project management. Her professional career includes internships at Shanghai ChemPartner Co., Ltd. and Jiangxi Zhby Biotech Co. Ltd., where she gained hands-on experience in molecular biology testing and research planning. Her current roles involve significant contributions to research in metabolic disorders and male infertility, with a focus on protein translocation and endosome pH regulation.
Contributions and Research Focus 🌟
Dr. Wang’s research primarily targets the intersection of metabolic disorders and drug development, specifically focusing on diabetic cardiomyopathy and the impact of Traditional Chinese Medicine on cardiac health. Her work includes investigating novel treatment strategies and exploring the mechanisms of substrate metabolism, protein translocation, and endosome pH regulation. Her expertise spans a wide range of molecular and cell biology techniques, including advanced imaging and bioinformatics.
Accolades and Recognition 🏆
Dr. Wang has made notable contributions to the field through her publications and presentations at various conferences. Her research on lipid-induced contractile dysfunction and diabetic cardiomyopathy has been recognized in leading journals and upcoming publications. Her work is highly regarded in the scientific community, reflecting her commitment to advancing healthcare solutions.
Impact and Influence 🌍
Dr. Wang's research has a profound impact on understanding and treating metabolic disorders, particularly in diabetic cardiomyopathy. Her innovative approaches and exploration of traditional medicine offer promising solutions for improving patient outcomes and advancing the field of metabolic disease research. Her contributions are shaping new therapeutic strategies and enhancing the quality of life for patients.
Legacy and Future Contributions 🚀
Dr. Wang's future endeavors are set to further explore and develop cutting-edge healthcare solutions. Her ongoing research aims to refine treatment strategies for metabolic disorders and improve the efficacy of drug development. By integrating advanced techniques and traditional medicine, she is poised to make significant strides in the field, contributing to a healthier future and advancing scientific knowledge.
Â
Publications đź“•
- đź“ť Specific Compounds Derived from Traditional Chinese Medicine Ameliorate Lipid-Induced Contractile Dysfunction in Cardiomyocytes
- Authors: Fang Wang, Dietbert Neumann, Dimitrios Kapsokalyvas, Martijn Hoes, Francesco Schianchi, Jan Glatz, Miranda Nabben, Joost J. F. P. Luiken
- Journal: International Journal of Molecular Sciences
- Year: 2024
- 📝 Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis
- Authors: Shujin Wang, Han YinYing, Ruimin Liu, Hou M, Dietbert Neumann, Jun Zhang, Wang F, Yumeng Li, Zhao X, Francesco Schianchi et al.
- Journal: Circulation Research
- Year: 2024
- 📝 Progestin and adipoQ receptor 7 (PAQR7) mediate the anti-apoptotic effect of P4 on human granulosa cells and its deficiency reduces ovarian function in female mice
- Authors: Li J, Liu Y, He J, Wu Z, Wang F, Huang J, Zheng L, Luo T
- Journal: Journal of Ovarian Research
- Year: 2024
- 📝 CD36 as a target for metabolic modulation therapy in cardiac disease
- Authors: Glatz JFC, Wang F, Miranda Nabben, Luiken JJFP
- Journal: Expert Opinion on Therapeutic Targets
- Year: 2021
- 📝 Diet-induced obesity is associated with altered expression of sperm motility-related genes and testicular post-translational modifications in a mouse model
- Authors: Wang F, Chen H, Chen Y, Cheng Y, Li J, Zheng L, Zeng X, Luo T
- Journal: Theriogenology
- Year: 2020
Â